2011
DOI: 10.1074/jbc.m110.171306
|View full text |Cite
|
Sign up to set email alerts
|

Identification of SPRED2 (Sprouty-related Protein with EVH1 Domain 2) as a Negative Regulator of the Hypothalamic-Pituitary-Adrenal Axis

Abstract: Sprouty-related proteins with EVH1 (enabled/vasodilatorstimulated phosphoprotein homology 1) domain (SPREDs) are inhibitors of MAPK signaling. To elucidate SPRED2 in vivo function, we characterized body homeostasis in SPRED2 ؊/؊ mice. They showed a doubled daily water uptake, induced by elevated serum osmolality, originating from increased blood salt load. Accordingly, serum aldosterone was doubled, accompanied by augmented adrenal aldosterone synthase (AS) expression. Surprisingly, serum vasopressin (AVP) was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 66 publications
0
12
0
Order By: Relevance
“…It seems more likely that ACTH-dependent aldosterone secretion, as defined, results from convergent signaling pathways from angiotensin II and ACTH, respectively, phospholipase C and adenylyl cyclase [ 36 ]. Cross-talk between these two activating systems may be modulated by several cellular signals as shown recently regarding Sprouty-related protein with EVH1 domain 2 [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…It seems more likely that ACTH-dependent aldosterone secretion, as defined, results from convergent signaling pathways from angiotensin II and ACTH, respectively, phospholipase C and adenylyl cyclase [ 36 ]. Cross-talk between these two activating systems may be modulated by several cellular signals as shown recently regarding Sprouty-related protein with EVH1 domain 2 [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, expression of protein tyrosine phosphatase, non-receptor type 7 (Ptpn7) was decreased with E2 treatment and may also be involved in ERK dephosphorylation [74]. In addition, expression of a repressor of MAP kinase activity, Spred2, [75] was modestly increased with E2 treatment. The fine-tuned expression of these genes by E2 highlights the balance that is needed between phosphorylation and dephosphorylation in the MAP kinase pathway [74].…”
Section: Methodsmentioning
confidence: 99%
“…In mammals, ETS TFs are associated with obesity regulation and behavioral states (31,32) pointing to a potentially conserved regulatory function.…”
mentioning
confidence: 99%